The rise of Sildenafil initially sparked a surge for the drug industry, however recent shifts present a uncertain picture for investors. Generic alternatives are eroding profits, and persistent litigation add more risk https://vinnyniaj945108.izrablog.com/41533273/sildenafil-and-big-pharma-a-volatile-investment